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 I Summary 
The adult central nervous system (CNS) is a highly plastic system that not only shows 
ultrastructural plasticity (e.g. the movement of processes of glia or the turnover of neuronal 
synapses), but it is also interspersed with proliferating cells that generate continuously new 
cells. Besides the proliferative-active stem cell niches, dividing NG2+ cells reside within the 
adult brain parenchyma. In particular, these NG2+ glia attracted attention as they also react 
to a variety of brain injuries by altered proliferation, e.g. after acute traumata, in brain 
tumors and in the case of neurodegenerative diseases and demyelinating diseases. However, 
little is known about the function and role of NG2+ cells in the adult brain in vivo. Therefore, 
the aim of this PhD study was to characterize the proliferative behavior of NG2+ glia in the 
intact and acutely lesioned brain parenchyma in order to determine regulatory mechanisms 
that control their proliferation. Here, it is shown that adult NG2+ cells are the major 
proliferative cell population in the adult cerebral cortex that is slowly dividing due to a long 
G1-phase. Interestingly, these cells can alter their cell cycle speed according to the 
environment: Increased neuronal activity resulted in a temporal reduction of NG2+ cell 
proliferation and simultaneously increased their differentiation. In contrast, after acute 
inflammatory conditions NG2+ cells acutely re-entered the cell cycle and proliferated faster 
than in the intact cortex. In order to follow these cells live and pursue their fate in the intact 
and injured adult CNS a novel transgenic mouse line was generated. Therefore, a bacterial 
artificial chromosome (BAC) was constructed, expressing an inducible fusion protein 
(iCreERT2) under the Sox10 promoter that allows mediating high recombination in NG2+ cells 
upon tamoxifen administration. This Sox10-iCreERT2 mouse line is now a new tool to gain 
further insights in the role and biology of adult NG2+ glia in the intact and lesioned brain, 
e.g. by cell- and time-specific ablation of distinct genes. 
 II Zusammenfassung 
Das erwachsene zentrale Nervensystem (ZNS) stellt ein plastisches System dar, das sich nicht 
nur durch ultrastrukturelle Plastizität (z.B. die Motilität der Fortsätze von Gliazellen oder 
Veränderungen neuronaler Synapsen) zeigt, sondern auch sich teilende Zellen enthält, die 
stetig neue Zellen produzieren. Neben den teilungsaktiven Stammzellnischen, befinden sich 
auch teilende NG2+ Zellen im umgebenden Gehirngewebe. Besondere Aufmerksamkeit 
haben diese NG2+ Gliazellen erhalten, nachdem gezeigt wurde, dass sie auch auf 
verschiedene Verletzungen des Gehirns mit einer veränderten Zellteilungsrate reagieren 
können, z.B. nach akuten Traumata, in Gehirntumoren, neurodegenerativen Erkrankungen 
und in demyelinisierenden Krankheiten. Jedoch ist bisher relativ wenig über die Funktionen 
und Aufgaben von NG2+ Zellen im erwachsenen Gehirn in vivo bekannt. Daher war es das 
Ziel dieser Doktorarbeit das Zellteilungsverhalten von NG2+ Zellen im gesunden und im akut 
geschädigten Gehirn zu untersuchen und dabei regulatorische Mechanismen zu klären, die 
das Teilungsverhalten dieser Zellen beeinflussen. In dieser Arbeit konnte gezeigt werden, 
dass NG2+ Gliazellen die größte sich teilende Zellpopulation in der erwachsenen zerebralen 
Kortex darstellen und sich langsam teilen, in dem sie länger in der G1-Phase des Zellzykluses 
verweilen. Interessanterweise können diese Zellen die Geschwindigkeit ihres Zellzykluses der 
Umgebung anpassen: Bei erhöhter neuronaler Aktivität teilen sich NG2+ Zellen zeitweise 
langsamer und differenzieren vorwiegend. Bei akuten Entzündungen im Gehirn können 
NG2+ Zellen jedoch sofort wieder den Zellzyklus beginnen und teilen sich damit schneller als 
in der gesunden Kortex. Um nun diese NG2+ Zellen live zu beobachten und ihre 
Nachkommen weiter zu verfolgen, wurde eine neue genetisch veränderte Mauslinie 
generiert. Ein künstliches Chromosom mit bakteriellen Ursprung (BAC) wurde konstruiert, in 
dem ein induzierbares Fusionsprotein (iCreERT2) unter dem Sox10-Promoter gebildet wird, 
wodurch nach Tamoxifen-Gabe NG2+ Zellen rekombiniert werden können. Diese neue 
Sox10-iCreERT2-Mauslinie bietet nun die Möglichkeit die Funktion und Biologie von NG2+ 
Gliazellen, z.B. durch die zell- und zeitspezifische Auslöschung von bestimmten Genen, zu 
untersuchen.  
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 1 Introduction 
Glial cells constitute one of the major cell population in the adult mammalian brain and can 
be divided into macroglia and microglia. In particular cells belonging to the group of 
macroglia can be further subdivided into astrocytes and oligodendrocytes providing either 
e.g. trophic support to neurons (reviewed in Nave and Trapp, 2008; Wang and Bordey, 2008) 
or facilitating neuronal conduction by enwrapping axons with myelin sheaths (reviewed in 
Trotter et al., 2010). These macroglial cells are not only morphologically heterogeneous in 
different areas of the central nervous system (CNS) but have also unique features, as for 
example a subpopulation of dividing macroglial cells persists in the adult intact brain (in the 
following referred to as “progenitors”). Besides the proliferative-active stem cell niches in 
the adult brain (Beckervordersandforth et al., 2010; Kriegstein and Alvarez-Buylla, 2009), 
parenchymal progenitors are widespread in the adult brain and are named either NG2+ cells, 
based on their antigenic expression profile, or oligodendrocyte progenitor cells (OPCs) as 
their progenies are mainly myelin-producing oligodendrocytes (Dimou et al., 2008; Kang et 
al., 2010; Nishiyama et al., 2009; Rivers et al., 2008). Therefore, these progenitors are 
historically considered to belong to the oligodendrocyte lineage. Notably, parenchymal 
progenitors are recently considered to constitute a 4th glial population, besides microglia, 
astrocytes and oligodendrocytes, due to their widespread distribution and unique properties 
in the mammalian brain (summarized in Nishiyama et al., 2009; Trotter et al., 2010). 
 
1.1 Origin and fate of parenchymal progenitors – the oligodendrocyte 
lineage 
Macroglial cells in the mammalian forebrain arise from the neuroepithelium and are 
generated at distinct time points during development (Wang and Bordey, 2008). In 
particular, the origin of OPCs in the CNS is heterogeneous which was first shown for the 
spinal cord (reviewed by Richardson et al., 2006)(Richardson et al., 2006). Here, the majority 
of OPCs in the spinal cord are generated from ventral domains at embryonic day (E) 12.5 
before they spread and populate the gray and white matter of the spinal cord (Richardson et 
al., 2006). However, a smaller proportion of the spinal cord OPCs also derives from dorsal 
sources later during development (Cai et al., 2005; Vallstedt et al., 2005). In line with this 
data, Kessaris et al. (2006) could show that also telencephalic OPCs are generated by 
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different precursors in three waves (Figure 1). The first cortical OPCs derive from ventral 
precursors at the ventricular zone of the medial ganglionic eminence (MGE) and anterior 
entopeduncular area, appearing around embryonic day (E) 11.5 (in mice) and enter the 
cerebral cortex at E16 (Kessaris et al., 2006). Although these OPCs are largely depleted 
postnatally, they are replaced by OPCs originating from dorsal precursors in the lateral 
ganglionic eminence (LGE) and from endogenous cortical precursors at the day of birth 
(Kessaris et al., 2006; Richardson et al., 2006). Interestingly, these precursors do not account 
for all OPCs in the adult telencephalon thereby indicating additional sources of adult OPCs 
(Ventura and Goldman, 2006) .  
 
 
Figure 1 Origin of NG2+ cells (OPCs) during development. The first OPCs derive from Nkx2.1+ precursors of the MGE and 
arrive in the cortex during the mid-neurogenesis. Gsh2+ progenitors of the LGE give rise to a second wave of OPCs. Finally, 
OPCs also derive from Emx1+ cortical progenitors. Gsh2+ and Emx1+ derived OPCs compensate the loss of Nkx2.1 derived 
OPCs and account for the majority of cortical OPCs postnatally. However, the contribution of Emx1-derived OPCs declined 
later on. aOPCs – oligodendrocyte precursor cells; MGE – medial ganglionic eminence; LGE – lateral ganglionic eminence 
(adapted from Kessaris et al. 2006) 
 
Postnatal OPCs differentiate into myelinating oligodendrocytes with a peak of myelination in 
the second postnatal week (Greenwood and Butt, 2003). However, not all postnatal OPCs 
differentiate but some also remain as progenitors in the adult CNS. These adult OPCs express 
similar antigens as their developmental counterparts (Figure 2), e.g. membrane proteins like 
neuron-glia antigen 2 (NG2; (Nishiyama et al., 1997), platelet-derived growth factor receptor 
α (PDGFRα; (Dawson et al., 2003), junctional adhesion molecule A (JAMA; (Stelzer et al., 
2010) and O4 (Nishiyama et al., 2009; Polito and Reynolds, 2005; Reynolds and Hardy, 1997; 
Sommer and Schachner, 1982) or the transcription factors OLIG2 (Takebayashi et al., 2002; 
Zhou et al., 2000) and SOX10 (Kuhlbrodt et al., 1998). Lately, it is proposed that adult OPCs 
differentiate via an intermediate state during which they express the G-protein coupled 
receptor 17 (GPR17; (Boda et al., 2011)). This intermediate state can be clearly distinguished 
by its morphology and antigenic expression profile (Figure 2) from mature oligodendrocytes 
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that express cytoplasmatic proteins like glutathione-S-transferaseπ (GSTπ), adenomatosis 
polyposis coli (APC/CC1) and aspartoacylase (ASPA). Whether these mature 
oligodendrocytes could further differentiate to myelinating oligodendrocytes in adult 
mammals was controversially discussed in the field of research as myelination should be 
finished within the first postnatal weeks (Greenwood and Butt, 2003). Only recently, 
independent research groups showed a continuous generation of new myelinating 
oligodendrocytes in the adult CNS (Dimou et al., 2008; Rivers et al., 2008). These myelinating 
oligodendrocytes express typical antigens being present in the myelin sheath, e.g. myelin-
associated glycoprotein (MAG), myelin oligodendrocyte glycoprotein (MOG), myelin basic 
protein (MBP) and myelin proteolipid protein (PLP/DM20; Figure 2; reviewed in Baumann 
and Pham-Dinh, 2001). One myelinating oligodendrocyte can ensheath several axons, 
thereby providing the basis for the fast saltatory conduction of action potentials between 
neurons (reviewed by Simons and Trotter, 2007), but also maintaining the axonal integrity 
(reviewed by Nave, 2010).  
 
Figure 2 The oligodendrocyte lineage in the adult CNS. Pictures showing recombined cells of the Sox10-iCreERT2 mouse line 
that are stained for GFP. These GFP-expressing cells label the oligodendrocyte lineage and allow discriminating distinct 
differentiation states of this lineage by morphology. The oligodendrocyte lineage comprises some proliferating NG2+ cells 
that can differentiate into mature oligodendrocytes over a GPR17+ intermediate state. If these intermediate cells might 
also become again NG2+, remains to be open (gray interrogation mark). However, depending on the brain region some 
mature oligodendrocytes can differentiate to myelin-sheath producing oligodendrocytes. Examples of antigen expression 
are given for each differentiation state of the oligodendrocyte lineage. 
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1.2 NG2+ glia (OPCs) – a 4th glial cell population 
Since OPCs are the major proliferating population in the adult brain parenchyma (Aguirre et 
al., 2004; Buffo, 2007; Dawson et al., 2000; Dawson et al., 2003; Dimou et al., 2008; Gensert 
and Goldman, 1997; Horner et al., 2000), these cells attract attention as a possible 
intracranial source for cellular regeneration upon disease conditions. OPCs constitute 5-8 % 
of cells in the mammalian brain (Horner et al., 2000) and remain constant in life (Dawson et 
al., 2003; Rivers et al., 2008). These glial cells are characterized by a stellate morphology 
with fine processes leaving from a central cell body and are uniformly distributed within the 
brain. Besides their fate to become mainly myelinating oligodendrocytes in higher 
vertebrates during development, these cells are already detectable in lower vertebrates with 
unmyelinated axons, suggesting additional functions of OPCs in the CNS (reviewed in Mangin 
and Gallo, 2011). Therefore, OPCs are recently considered to be a 4th glial population and are 
in the following referred to as “NG2+ cells” due to their diverse nature.  
 
Cellular characteristics of NG2+ glia 
NG2+ cells form a network with slightly overlapping domains in the CNS and are tightly 
integrated within the astrocytic and the neuronal network (Wigley and Butt, 2009). It is 
shown that they can form contacts with unmyelinated and myelinated axons, neurons, 
astrocytes and pericytes allowing probably a bidirectional communication between these 
cells and NG2+ glia (Hamilton et al., 2010; Wigley and Butt, 2009). While the contact of NG2+ 
cells to pericytes might be involved in regulating the blood flow (Wigley and Butt, 2009), the 
synaptic contact of NG2+ glial processes to neurons, e.g. at the nodes of Ranvier, the 
neuronal soma and the dendrites, might have an impact on diverse cellular functions like 
migration and maturation of NG2+ glia (Mangin and Gallo, 2011). These synapses between 
neurons and NG2+ cells can be either glutamatergic or γ-aminobutyric acid (GABA)-ergic 
(reviewed in Mangin and Gallo, 2011) mediating excitatory (EPSC) or inhibitory postsynaptic 
currents (IPSC) in NG2+ cells via α–amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA) receptors (Figure 3) or GABAA receptors, respectively (reviewed in Mangin and Gallo, 
2011). The resulting currents are transduced in a locally restricted increase in Ca2+ in NG2+ 
glial processes (Figure 3; (Bergles et al., 2000; Blaustein and Lederer, 1999; De Biase et al., 
2010; Hamilton et al., 2010; Lin et al., 2005; Mangin et al., 2008; Tong et al., 2009)). In 
addition, the EPSC/ IPSC induced opening of voltage-dependent Na+ channels might even 
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result in the generation of action potentials in NG2+ cells (Karadottir et al., 2008), although 
this is still controversially discussed (reviewed by Frohlich et al., 2011).  
 
 
Figure 3 Scheme depicting the formation of a glutamate-mediated (Glu) tripartite contact between neurons, astrocytes 
and NG2+ cells in the gray and white matter. In the cortical gray matter, NG2+ cells form a synaptic contact to neurons. 
Glutamate, released by neurons, results in an intracellular increase of Ca2+in NG2+ cells by Ca2+-permeable AMPA receptors. 
In contrast, the neurotransmitter transmission between NG2+ cells and axons in the white matter is probably mediated via 
ectopic transmission, spillover or diffuse volume transmission (reviewed in Maldonado, 2011). (adapted from Nishiyama et 
al. 2009) 
In contrast, Hamilton et al. (2010) suggests that ATP, released by neurons and astrocytes 
upon neuronal activity under physiological conditions, is a key signaling molecule that results 
in a widespread intracellular Ca2+ increase in NG2+ glia. ATP and its metabolites are well-
known as sensors in energy metabolism and cellular homeostasis (reviewed by Butt, 2011) 
and are shown to bind to metabotropic P2Y and ionotropic P2X receptors on NG2+ cells 
(Hamilton et al., 2010). Besides glutamate and ATP, the activation of muscarinic and nicotinic 
acetylcholine receptors (AChR; (Cui et al., 2006; Velez-Fort et al., 2009)) and cannabinoid 
receptors (Mato et al., 2009) on NG2+ glia are also shown to alter their intracellular Ca2+ 
level. This signaling onto NG2+ glia, via all these different released transmitters, has 
pronounced roles in the proliferation, differentiation and migration ability of NG2+ cells in 
vitro (Agresti et al., 2005a; Chen et al., 2009; Gallo et al., 1996; Ghiani et al., 1999; Gudz et 
al., 2006; Tong et al., 2009; Yuan et al., 1998). However, the impact of transmitters onto 
NG2+ cells in vivo under physiological conditions in the intact CNS is unknown. Therefore, a 
fate mapping approach was established during my PhD thesis in order to follow proliferating 
NG2+ cells and to discriminate environmental influences onto them in vivo.  
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The fate of NG2+ glia 
Although NG2+ cells belong to the oligodendrocyte lineage (as described above) and seem to 
have a restricted fate, several publications challenged this point of view over the last 
decades of research. Early in vitro data of white matter (WM)-derived, postnatal NG2+ cells 
proposed a broader potential of these cells as they can give rise to type-2 astrocytes as well 
as oligodendrocytes (Raff et al., 1983; Shi et al., 1998; Wolswijk and Noble, 1989; Wren et 
al., 1992). Therefore, NG2+ glia are also termed “O-2a” precursor cells in literature. In 
addition, postnatal NG2+ cells are shown to grow as neurospheres (a generally accepted in 
vitro method to test cells for their stem cell potential (Jensen and Parmar, 2006)) and can be 
differentiated into oligodendrocytes, astrocytes and neurons in vitro (Aguirre and Gallo, 
2004; Aguirre et al., 2004; Belachew et al., 2003; Kondo and Raff, 2000). Interestingly, WM-
derived NG2+ cells seem to keep this multipotency also until adulthood (Nunes et al., 2003) 
whereas NG2+ cells of other brain regions seem to lose this property (Buffo et al., 2008). In 
contrast, in vivo data suggest a restriction of the multilineage-potential of NG2+ glia to early 
embryonic stages, shown by giving rise to neurons, astrocytes and oligodendrocytes,  
(Masahira et al., 2006). At later stages the fate of NG2+ cells is successively restricted to 
generate only astrocytes and oligodendrocytes (E16.5; (Zhu et al., 2008)) or solely 
oligodendrocytes in the postnatal and adult brain (Dimou et al., 2008; Kang et al., 2010; Zhu 
et al., 2011). There is also now a growing body of evidence that adult NG2+ cells can 
generate astrocytes after several types of injury (Busch et al., 2010; Komitova et al., 2011; 
Sellers et al., 2009; Tatsumi et al., 2008). Although so far other studies failed to confirm this 
so far (Barnabe-Heider et al., 2010; Dimou et al., 2008; Kang et al., 2010; Zawadzka et al., 
2010), suggesting that this lineage plasticity may depend on the injury site and condition. In 
addition to the controversy about the astrocytic potential of adult NG2+ glia, the potential of 
these cells to generate neurons in vivo is highly debated (reviewed by Richardson et al., 
2011). There are publications suggesting the generation of neurons by NG2+ glia at distinct 
regions in the brain at postnatal stages (Aguirre and Gallo, 2004; Aguirre et al., 2004; 
Belachew et al., 2003) and adult stages (Guo et al., 2010; Rivers et al., 2008). However, these 
data could not be confirmed by others (Dimou et al., 2008; Kang et al., 2010; Zhu et al., 
2011). Thus, one explanation may be leakiness of the used transgenic lines (Kang et al., 
2010). On the other hand, other mouse lines (e.g. Olig2CreERTM) showed a very low 
recombination rate raising concerns about the detection of only a subpopulation of NG2+ 
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cells (Dimou et al., 2008; Richardson et al., 2011). In order to unravel the fate of NG2+ cells 
in the adult cortex, a mouse line independent approach was chosen in my PhD thesis to 
circumvent the described difficulties above.  
 
1.3 Acute cortical injury as a model for glial scar formation 
Traumatic brain injury, e.g. mechanical lesions or ischemia, causes stressed or dying cells at 
the site of injury as well as in retrograde connected cortical areas (reviewed by Viscomi et 
al., 2009)y to release molecules, e.g. heat shock proteins, nucleotides, glutamate and 
metalloproteinases (MMPs), that initiate an inflammatory response around the primary 
lesion site (reviewed by Pineau and Lacroix, 2009). Within this process of inflammation the 
composition of the extracellular matrix is altered and different cells are recruited within the 
lesion site in a time-dependent manner, e.g. microglia, astrocytes, NG2+ cells, blood cells 
and other vascular cells (if the blood-brain barrier (BBB) was disrupted) as well as connective 
tissue (fibroblasts; if the meninges were injured; (Fawcett and Asher, 1999; Kerschensteiner 
et al., 2009; Rolls et al., 2009)). These alterations in the tissue structure persist in the lesion 
side for weeks and thereby create a glial scar. The formation of a scar around the damaged 
area is an immediate response to seal off the lesion side from the intact brain areas and to 
restore homeostasis during the acute phase of the injury (Rolls et al., 2009). However, at 
later time points (chronic phase) the glial scar can inhibit regenerative mechanism, e.g. 
replacement of damaged neurons, axonal growth and remyelination (Alilain et al., 2011; 
Fawcett and Asher, 1999; Silver and Miller, 2004).  
 
Reaction of NG2+ glia upon traumatic brain injury 
 
NG2+ cells respond to variety of acute traumata in the CNS, e.g. viral infection (Levine et al., 
1998), demyelinating lesions (Di Bello et al., 1999; Keirstead et al., 1998; Levine and 
Reynolds, 1999; Zawadzka et al., 2010) and mechanical injuries (Alonso, 2005; Buffo et al., 
2005; Hampton et al., 2004; Levine, 1994; Lytle et al., 2006; McTigue et al., 2001; Zai and 
Wrathall, 2005). Upon acute injuries, there is an increased extracellular level of 
excitatory/inhibitory neurotransmitters (Karadottir et al., 2008) and ATP/adenosine (Matute, 
2011) that results in a (prolonged) activation of AMPA receptors as well as P1 and P2 
receptors on NG2+ cells, respectively. Both mechanisms can cause an increased death of 
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glial cells (Karadottir et al., 2008; McTigue and Tripathi, 2008). However, remaining NG2+ 
cells within the lesion site undergo morphological changes as shown by shortening and 
thickening of their processes and cellular hypertrophy (reviewed by Levine et al., 2001). In 
addition, NG2 expression is increased after acute injury, not only in NG2+ glia but also in 
meningeal cells, pericytes and in the extracellular matrix (ECM) surrounding the injury 
(Fawcett and Asher, 1999; Jones et al., 2002; Levine et al., 2001; Tang et al., 2003). In 
particular, the accumulation of NG2 in the ECM is due to the release of the extracellular 
glycosaminoglycans chains of NG2 by proteases (Nishiyama et al., 2009; Trotter et al., 2010). 
Otherwise, NG2 localized on NG2+ cells is shown to have a supportive role by stabilizing 
axons within the lesion side against inflammatory-associated dieback (Figure 4; (Busch et al., 
2010)). But at the same time they prevent axonal regeneration after lesion (Chen et al., 
2002; Tan et al., 2006). Therefore, the number of NG2+ glia in the lesion site has a profound 
impact on the regenerative capacity of the CNS showing the importance to analyze the 
proliferative response of NG2+ cells upon acute injury and to determine its regulation. 
 
 
Figure 4 Scheme showing an acute lesion side. Although the lesion core contains mainly macrophages, the surrounding 
lesion area (penumbra) is composed of reactive astrocytes, reactive NG2+ glia and microglia (not depicted herein). Upon 
injury NG2+ cells support regrowing axons and help them to even pass the injury site by protecting them from macrophage 
associated axonal dieback. (adapted from Busch et al. 2010) 
 
Reaction of microglia upon traumatic brain injury 
However, NG2+ cells are not the only glial population reacting to injury. In order to gain 
further insights in the mechanism influencing the proliferation of NG2+ cells upon acute 
injury, one approach could be to correlate their response to the reactivity of other glial cells. 
Another cell type that responds immediately to lesions, e.g. brain structure disruption, 
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energy deprivation (e.g. during ischemia) or viral/bacterial infections, are microglia. They 
start to express and release proinflammatory chemokines and cytokines early after lesion 
(Pineau and Lacroix, 2007). However, the level of microglia reactivity depends on the 
severity of the injury. So traumatic lesions with disruption of the BBB can cause 
morphological alterations in microglia, e.g. retraction of their processes and hypertrophy 
(reviewed in (Kettenmann et al., 2011). In addition, these cells increase in number around 
the lesion by migration (Davalos et al., 2005; Nimmerjahn et al., 2005) as well as by 
proliferation (Fawcett and Asher, 1999; Kettenmann et al., 2011). In particular, upon 
activation microglia up-regulate the expression of Iba1, CD45 and CD11b (Kettenmann et al., 
2011). The latter protein is part of the innate immune system and involved in phagocytosis 
of cellular debris and dead cells (Ma et al., 2003). At the same time activated microglia are 
able to secrete for example cytokines (that trigger the invasion of leukocytes into the brain 
parenchyma), MMPs, reactive oxygen species and nitric oxid that have detrimental roles and 
might augment the tissue destruction in the CNS (Figure 5;(Kerschensteiner et al., 2009; 
Rolls et al., 2009; Wang et al., 2007)). In contrast, microglia also release factors that are 
neuroprotective, thereby supporting tissue remodeling and repair (Figure 5; reviewed in 
(Kerschensteiner et al., 2009; Kreutzberg, 1996)). This two-sided role of microglia could 
depend on the severity of the lesion, in particular of the disruption of the BBB, and the state 
of the lesion (acute phase in contrast to chronic lesions; (Kerschensteiner et al., 2009; 
Kreutzberg, 1996; Wang et al., 2007)). 
 
  
 
Figure 5 Scheme summarizing factors that are released by microglia amongst others upon acute inflammation and 
grouped according their effect on neurons into pro-inflammatory and anti-inflammatory cues. (adapted from 
Kerschensteiner et al. 2009) 
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Reaction of astrocytes upon traumatic brain injury  
 
Besides NG2+ cells and microglia, also astrocytes respond to a variety of brain injuries 
including for example viral infections, acute traumata (e.g. stroke and ischemia) and 
neurodegenerative mechanism, in a process named astrogliosis (Sofroniew and Vinters, 
2010). The degree of the gliotic reaction of astrocytes depends on the severity of the lesions, 
e.g. site of the lesion and BBB breakdown (Sofroniew and Vinters, 2010). The reaction of 
astrocytes comprises the up-regulation of distinct intermediate filaments (e.g. glial fibrillary 
acidic protein (GFAP), vimentin and nestin), cell body hypertrophy, thickening of their 
processes and an increased number around the injury site (Figure 6; (Buffo et al., 2010; 
Robel et al., 2011b; Sofroniew and Vinters, 2010)). In the intact brain parenchyma, 
astrocytes are quiescent whereas upon (severe) injury conditions reactive astrocytes re-
enter the cell cycle and thereby increase in number around the lesion site. Due to these 
cellular alterations astrocytes form a tight barrier that restricts the area of inflammation and 
its associated neuronal cell death (Sofroniew, 2009; Sofroniew and Vinters, 2010). However, 
the long-term effect of astrogliosis is rather harmful. Reactive astrocytes are prone to 
secrete chondroitin sulphate proteoglycans, e.g. aggrecan, brevican, neurocan (Fawcett and 
Asher, 1999), after lesion that are all known to inhibit regeneration (Silver and Miller, 2004).  
In addition, reactive astrocytes in the brain parenchyma mimic features, e.g. antigen 
expression profile and proliferation, of astrocytes in the stem cell niches of the intact CNS 
and therefore attracted attention as a possible in vivo source to regenerate neurons (Robel 
et al., 2011b). In particular, Buffo et al. (2008) showed a stem cell potential for reactive 
astrocytes in the brain parenchyma upon acute injury by using the Glast::CreERT2 mouse line 
that labels astrocytes and their progeny in vivo. These recombined astrocytes can grow in 
vitro as multipotent neurospheres by giving rise to neurons, astrocytes and oligodendrocytes 
upon differentiation (Buffo et al., 2008). However, there is so far no in vivo evidence that 
reactive astrocytes can generate new neurons upon acute injury without further 
manipulation (Barnabe-Heider et al., 2010; Buffo et al., 2008; Tatsumi et al., 2008).  
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Figure 6 Scheme summarizing the reaction of gray matter astrocytes upon acute injury. Astrocytes react to traumata by 
morphological changes and the up-regulation of certain antigens, for example GFAP, nestin, vimentin and BLBP. Depending 
on the severity of the lesion reactive astrocytes start to proliferate, therefore being Ki67+ and incorporating BrdU. BrdU – 
5’bromo-desoxyuridine, GFAP – glial fibrillary acidic protein, BLBP – brain lipid-binding protein, DSD1 – DSD1 proteglycan, 
TNC – tenascin(adapted from Robel et al. 2011) 
 
Nevertheless, these data also show the importance of genetically modified mouse lines in 
order to gain further insights in the reactivity and potential of astrocytes upon acute injury in 
vivo. Besides the fate-mapping, such modified mouse lines are essential tools (e.g. 
Glast::CreERT2 line) to determine new molecular mechanism. For example the deletion of the 
RhoGTPase Cdc42 in astrocytes in vivo resulted in an increased number of microglia upon 
acute cortical injury (Robel et al., 2011a). In order to understand now the role and function 
of proliferating NG2+ cells and their interaction with other cell types after lesion, genetically 
modified mouse lines are engineered to specifically target NG2+ cells. 
 
1.4 Transgenic animal models to fate-map and to manipulate NG2+ glia  
The most common approaches to target time and tissue-specific cells are the 
tetracycline/doxycycline system and the Cre/loxP system (reviewed by Bockamp et al., 
2002). In particular, the latter system contains the site-specific DNA recombinase Cre, being 
originally expressed in the P1 bacteriophage (Sauer, 1998). This recombinase recognizes 
distinct DNA sequences (loxP sites) and excises/ inverts the DNA sequence located between 
two loxP sites. Such loxP sites are most often used to (1) flank a stop cassette in front of a 
reporter gene, e.g. green fluorescent protein (GFP), to visualize successfully recombined cells 
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or (2) flank a gene of interest for loss-of-function experiments upon recombination. The 
efficiency of the Cre-mediated recombination is between 80-100%, but one recombination 
event requires at least four Cre molecules (Sauer, 1998). Temporal control can be acquired 
by fusing Cre to a mutated estrogen-receptor binding domain (ER) that has a higher affinity 
for synthetic estrogens (e.g. tamoxifen (Tam) and its metabolite 4-hydroxy-tamoxifen (OHT)) 
than for the endogenous estrogen (Jaisser, 2000). The advantage of the CreER system is its 
localization in the cytosol. Only after tamoxifen application the fusion protein is translocated 
in the nucleus (Figure 7). 
  
 
Figure 7 Cartoon summarizing the Cre/loxP system using the example of Olig2::CreERTM mice crossed to a green 
fluorescent protein (GFP) reporter mouse line. Olig2CreERTM mice express CreERTM in the cytosol of Olig2 expressing cells. 
By administrating tamoxifen to the mice, tamoxifen and its metabolite 4-hydroxy-tamoxifen can pass the blood brain 
barrier and bind to the estrogen component of the CreERTM protein. Thereby, CreERTM will be translocated to the nucleus 
where the Cre recombinase can bind to the loxP sites within the DNA and removes the stop-cassette in front of the GFP. 
Thus, GFP will be expressed in Olig2+ cells and will remain expressed in Olig2+ progeny and Olig2- progeny, independently 
of the expression of Olig2.  
 
Several ER constructs exist using either the mouse estrogen receptor (ERTM; (Vasioukhin et 
al., 1999)) or the human estrogen receptor (ERT or ERT2 – an improved ERT-version that is 
more sensitive to OHT (Indra et al., 1999; Metzger et al., 1995)). In addition to this temporal 
specificity, tissue-specificity can be achieved by expressing CreER under a gene-specific 
promoter, typically expressed within the tissue of interest. The most reliable cell-specific 
expression of CreER is achieved by knock-in of CreER into the endogenous gene locus. The 
disadvantage is however that only one CreER molecule is inserted in the endogenous locus, 
resulting probably in low recombination rate as it is the case in the Olig2::CreERTM mouse 
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line (Masahira et al., 2006). Although preserving the endogenous expression at a lower level 
in heterozygote knockin-mice, this can already alter the cellular homeostasis, causing cellular 
and behavioral abnormalities, e.g. in the Sox10-lacZ mice (Britsch et al., 2001; Ludwig et al., 
2004). To overcome these limitations, transgenic mice can be generated by random 
integration of conventional bacterial vectors (e.g. pBluescript), expressing CreER, within the 
genome that would not influence endogenous expression levels. However, the integration 
side of these vectors can result in a cellular and tissue-dependent inaccurate expression of 
CreER. In addition, these bacterial vectors have a limited cloning capacity and contain usually 
a “minimal”-promoter in front of the gene of interest. Using parts of the promoter that are 
not well characterized or the lack of distal regulatory elements within these vectors might 
cause CreER-misexpression. In contrast, the use of bacterial artificial chromosomes (BACs) 
would circumvent such a limitation by inserting between 100-250 kilo basepairs (kb) of non-
bacterial DNA into the BAC. In addition, it is shown that BACs can integrate multiple times 
within the genome which would result in a higher CreER expression and better 
recombination rate (Chandler et al., 2007).  
So far different inducible mouse lines are published targeting NG2+ cells and are 
summarized in Table 1. However, some of the available mouse lines either have a low 
recombination rate in NG2+ glia and thereby risk the analysis of a subpopulation of NG2+ 
cells (as mentioned above) or target different cell types besides the oligodendrocyte lineage.  
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Table 1 Summary of inducible transgenic mouse lines to target NG2+ glia 
Mouse line Type of 
transgenic 
mice 
Recombination 
efficiency in 
adult NG2+ 
glia 
Recombined 
cell types in 
the adult CNS 
Literature 
reference 
Olig2::CreERTM Knockin; Olig2 
gene locus 
low NG2+ cells, 
mature 
oligodendrocytes, 
astrocytes, few 
neurons 
(Dimou et al., 
2008; Tatsumi 
et al., 2008) 
NG2-CreERTM Bac-transgenic 
(RPCI 23-library) 
low NG2+ cells, 
mature 
oligodendrocytes 
(Zhu et al., 
2008; Zhu et 
al., 2011) 
PDGFRα-CreERTM Bac-transgenic 
(RP24-148N4) 
high NG2+ cells, few 
neurons, 
pericytes, choroid 
plexus  
(Kang et al., 
2010) 
PDGFRα-CreERT2 PAC-transgenic 
(PAC 546-M3) 
high NG2+ cells, 
mature 
oligodendrocytes, 
(neurons) 
(Rivers et al., 
2008) 
Plp1-CreERT2 Transgenic 
(2.4 kb Plp1-
promoter 
fragment) 
low NG2+ cells, 
mature and 
myelinating 
oligodendrocytes, 
neurons, 
astrocytes 
(Doerflinger et 
al., 2003; Guo 
et al., 2010; 
Kang et al., 
2010) 
 
 2 Aim of the study 
Given the importance of NG2+ glia the purpose of my study was to determine the 
proliferative behavior and the fate of NG2+ glia in the intact adult CNS and after acute injury. 
Therefore, the following questions were addressed: 
1) How long is the cell cycle length of NG2+ cells in the intact cortical gray matter? 
2) Do all NG2+ cells divide in the intact cortex? 
3) Do NG2+ cells change their proliferative behavior under altered environmental 
conditions?  
4) What is the fate of NG2+ glia in the intact and acutely injured cortex? 
Thus, the cell cycle length of NG2+ cells in the intact cortical gray matter of rodents was 
determined first, in order to characterize then their proliferative response to two altered 
environmental conditions: (1) Acute cortical injury in the model of stab wound injury and (2) 
Physiologically increased neuronal activity by physical exercise (running wheel experiments). 
In addition, the fate of NG2+ cells was analyzed in two different ways either by 
characterizing the progeny of proliferating NG2+ cells with BrdU-retaining studies or by 
tracing the fate of randomly labeled NG2+ cells, comprising proliferating as well as non-
proliferating NG2+ cells, by using the Olig2::CreERTM mouse line (as described above). Given 
the low recombination rate in this genetically modified mouse line, I generated a new mouse 
line using a BAC-transgene that contains an improved Cre variant (iCre) fused to the ERT2, as 
a basis to achieve high recombination rates. The transcription factor Sry-related high 
mobility group box protein 10 (Sox10) was chosen to drive the expression of iCreERT2, having 
the advantage that the distal regulatory elements of Sox10 are well-described and Sox10 is 
exclusively expressed in the oligodendrocyte lineage in the adult CNS. Then the 
characterization of this new mouse line by fate-mapping analysis was intended. 
 
 
 3 Results 
This chapter is split into three paragraphs, each of them representing an independent study 
that is already published or under revision in international peer-reviewed journals. The main 
results are summarized below and the contributions of the single authors to each study are 
provided.  
 
 
 3.1 Proliferative behavior of NG2+ glia and the regulation by acute injury and 
physical activity 
This study herein is published as “Progenitors in the Adult Cerebral Cortex: Cell Cycle 
Properties and Regulation by Physiological stimuli and injury” by Simon C, Dimou L and Götz 
M in Glia 2011, 59: 869-881.  
Here, I examined the cell cycle length of NG2+ glia in the adult cerebral cortex and the 
impact of environmental cues on the proliferative behavior of NG2+ glia. By administrating 
BrdU to wild type mice combined with immunohistochemical stainings for BrdU and Ki67 (an 
antigen highly expressed from the S- to M-phase), the cell cycle length of NG2+ cells in the 
adult cerebral GM was determined. NG2+ glia in the intact cortical GM had an impressively 
long cell cycle length. Interestingly, while the S- to M-phase took only five days these cells 
remained in the G1-phase for at least 32 days. Despite this, proliferating NG2+ cells can 
either re-enter the S- to M-phase and thereby self-renew, or enter the G0-phase and 
differentiate into mature oligodendrocytes. In addition, within a three day time window only 
12% of the NG2+ cells proliferated whereas 80% of them divided within three months, 
thereby showing that NG2+ glia divide in an asynchronous manner. However, NG2+ cells can 
considerably shorten their cell cycle length in response to the environment. Stab wound 
injury resulted in an acute re-entry of the majority of NG2+ cells surrounding the injury site 
into the cell cycle. In contrast, increased physical exercise resulted in a temporarily increased 
exit of the cell cycle of NG2+ cells accompanied by fast differentiation. In summary, this 
study suggests a modulation of the cell cycle length of NG2+ glia by environmental 
influences. Thus, NG2+ glia proliferation and oligodendrocyte generation is profoundly 
influenced by environmental cues – a finding with implications for other pathologies, such as 
epilepsy and Multiple Sklerosis. 
 
Contribution of the authors 
The herein published experiments and analysis were done by me as well as the writing of the 
manuscript. L. Dimou and M. Götz thoroughly revised the manuscript, planned experiments and 
discussed implications of the results. The study was financed by M. Götz. 
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 3.2 Fate of NG2+ glia in the cortical gray and white matter 
This study herein is published as “Progeny of Olig2-Expressing Progenitors in the Gray and 
White Matter of the Adult Mouse Cerebral Cortex” by Dimou L, Simon C, Kirchhoff F, 
Takebayashi H and Götz M in Journal of Neuroscience 2008, 28 (41): 10434-10442.  
NG2+ cells are potent progenitors that give rise to myelinating oligodendrocytes postnatally. 
Although NG2+ cells are a widespread cell population in the adult CNS, the fate of these cells 
in adult mammals was largely unknown at the time of this study. In order to analyze the 
progeny of NG2+ cells in the adult  mouse brain, the Olig2::CreERTM mouse line, crossed to 
the Z/EG, GFP or R26R-reporter mouse line, was used as Olig2 is expressed in nearly all 
proliferating NG2+ cells in the brain parenchyma. However, Olig2 expression is not restricted 
to the oligodendrocyte lineage in Olig2::CreERTM mice, but also recombines in some 
parenchymal astrocytes and in very few neurons. Despite the low reporter expression 
outside of the oligodendrocyte lineage, this study revealed intriguing regional differences in 
the progeny of NG2+ glia. NG2+ cells in the adult cerebral white matter (WM) mainly gave 
rise to new myelinating oligodendrocytes whereas NG2+ cells in the cerebral gray matter 
(GM) the majority remained as NG2+ glia and only gave rise only to few maturate (but not 
myelinating) oligodendrocytes. This regional heterogeneity can be either due to intrinsic 
differences in NG2+ cells, e.g. cell cycle differences as suggested within this publication, or 
be instructed by the environment. In summary, this study shows the generation of new 
myelinating and mature oligodendrocytes throughout life with an intriguing difference in 
gray and white matter regions.  
 
Contribution of the authors 
I performed the proliferation experiments in C57BL/6 mice by administrating 5’-bromo-desoxyuridine 
(BrdU) to the mice to label dividing cells. Following perfusion, I did the sectioning, staining and 
quantifications for Olig2+/ BrdU+ cells in the adult CNS (as shown in Suppl. Fig. 1). L. Dimou did all 
the experiments and analysis in the Olig2::CreERTM mice that were kindly provided by H. Takebayashi. 
F. Kirchhoff kindly provided the Plp-DsRed mice. The experiments were planned and the manuscript 
was written by L. Dimou and M. Götz. M.Götz financed this work. 
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 3.3 Generation and characterization of the Sox10-iCreERT2 mouse line 
The revised manuscript of this study is submitted as “Sox10-iCreERT2: a mouse line to 
inducibly trace the neural crest and oligodendrocyte lineage” by Simon C, Lickert H, Götz M 
and Dimou L (2011). 
Here, the generation and use of a new transgenic mouse line to target exclusively the 
oligodendrocyte lineage in the adult CNS with high efficiency is described. We generated a 
BAC-transgenic mouse with the expression of an improved Cre (iCre) fused to the ERT2 under 
the Sox10 promoter. I characterized two BAC lines which both recombine in NG2+ cells with 
high efficiency and specificity. During development Sox10 is also expressed in neural crest 
and its derivatives and in the adult peripheral nervous system. Thus, the Sox10-iCreERT2 
mouse line is also a new potent tool to study distinct progeny of the neural crest at different 
developmental stages. Indeed, by inducing recombination at early embryonic stages we 
showed that pericytes in the adult brain are the progeny of the neural crest. This result is in 
contrast to the notion that CNS pericytes belong to the hematopoietic system and therefore 
have a mesodermal origin. In summary, the Sox10-iCreERT2 mouse line is a powerful tool to 
gain further insights in the biology of neural crest cells and the oligodendrocyte lineage.  
 
Contribution of the authors 
The generation of the mouse line, comprising the cloning, sequencing and purification of the BAC-
transgenic construct, and the characterization of this new mouse line was performed by me (except 
the fusion of the iCre to the ERT2 sequence). H. Lickert helped with his technical know-how and 
provided additionally several vector constructs for cloning. The manuscript was written by me and 
revised by H. Lickert, M. Götz and L. Dimou. This study was directed by H. Lickert, M. Götz and L. 
Dimou. 
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 4 Discussion 
4.1 Adult NG2+ glia – a slow cycling and self-renewing cell population 
NG2+ glia are the predominant proliferating cells outside the neurogenic niches in the adult 
intact CNS (Dawson et al., 2003; Dimou et al., 2008; Gensert and Goldman, 2001; Horner et 
al., 2000; Simon et al., 2011a). In the cortical GM these cells have a cell cycle length of about 
37 days with a particular long G1-phase (Simon et al., 2011a), being in line with other recent 
publications in humans and rodents (Geha et al., 2010; Psachoulia et al., 2009). Notably, the 
cell cycle length of NG2+ cells increases with age that might be due to a further prolongation 
of the G1-phase (Lasiene et al., 2009; Psachoulia et al., 2009) and results in a decrease in 
differentiation (Kang et al., 2010; Zhu et al., 2011). This age-dependent alteration of the cell 
cycle is not specific for parenchymal progenitors, but has already been described for 
neuroepithelial precursors, as for example during development (Takahashi et al., 1995). 
Here, the length of the G1-phase of neuroepithelial progenitors increases during 
embryogenesis and can be even correlated to the fate of neuroepithelial progenitors and the 
mode of cell division (reviewed in Gotz and Huttner, 2005). In short, this cell cycle length 
hypothesis suggests that during early neurogenesis neuroepithelial progenitors (with a short 
G1-phase) divide symmetrically by expanding their pool. Later on, these progenitors have a 
prolonged G1-phase and will divide asymmetric by giving rise to a neuron and a 
neuroepithelial progenitor or symmetrically by generating two neurons (Gotz and Huttner, 
2005). Then, at adult stages the stem cells in the neurogenic niches divide mainly 
asymmetric by giving rise to another stem cell and to a intermediate progenitor that can 
generate continuously new neurons via symmetric divisions in vitro (Costa et al., 2011). 
However, adult NG2+ glia have been shown to divide mainly symmetrically in vivo, according 
to their morphology and receptor distribution (Ge et al., 2009). In contrast, recent data now 
provide more evidence that a considerable proportion of NG2+ glia divides also asymmetric 
when analyzing NG2 and epidermal growth factor receptor (EGFR) expression (Sugiarto et 
al., 2011) and thereby supporting previous publications in vivo (Polito and Reynolds, 2005; 
Zhu et al., 2011). In summary, these in vivo data suggest heterogeneity amongst proliferating 
NG2+ cells: Some NG2+ cells divide symmetrically and either remain NG2+ or give rise to two 
mature oligodendrocytes or divide asymmetrically with one daughter cell to remain NG2+ 
and the other one to differentiate. However, it remains open whether there is a similar 
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relationship between the cell cycle length and the mode of division for NG2+ cells as it is 
shown for neural-glial progenitors. Instead, the age-dependent alterations of the cell cycle 
length of NG2+ glia and their differentiation seem to be rather complex. Their proliferation/ 
differentiation behavior might reflect intrinsic differences (Shi et al., 1998), changes in the 
access to growth factors that are released by neighboring cells, e.g. neurons, astrocytes and 
endothelial cells (Arai and Lo, 2009a, 2009b; Kang et al., 2010), or simply the reduced need 
of mature oligodendrocytes with age.  
Despite the fact that adult NG2+ cells can differentiate into mature oligodendrocytes (Dimou 
et al., 2008; Kang et al., 2010; Rivers et al., 2008; Zhu et al., 2011), the number of NG2+ glia 
remains constant over life (Rivers et al., 2008), thereby suggesting indirectly that these cells 
can self-renew. In my study I could provide for the first time direct evidence that NG2+ cells 
in the intact brain parenchyma can self-renew. In addition, radiation experiments of the 
adult cortex, causing a depletion of NG2+ glia, showed a subsequent restoration of the NG2+ 
glial network by the remaining NG2+ progenitors (Irvine and Blakemore, 2007; Panagiotakos 
et al., 2007). Therefore, these data suggest a feedback mechanism between NG2+ cells to 
regulate their cellular density. However, less is known about it on a molecular basis 
(reviewed by Orentas and Miller, 1998). Results of primary oligodendrocytes cultures 
propose a regulatory system that is independent of other cell types, e.g. astrocytes and 
neurons (Zhang and Miller, 1996), and does not rely on the coupling of NG2+ glia to other 
cells by gap-junctions or electrical activity (Von Blankenfeld et al., 1993). Therefore, to keep 
the NG2+ cell population constant a remaining model might consist of cell-cell contacts 
mediated by glycoproteins, as shown for fibroblasts (Wieser et al., 1990), and/ or a locally 
restricted autocrine release of proliferative factors by NG2+ cells. In the future, it might be 
important to define the mechanisms that control NG2+ cell density as these cells are the 
basis to generate mature (myelinating) oligodendrocytes. Failure in repopulation of a 
functional NG2+ glial network could result in demyelination (Panagiotakos et al., 2007), that 
contributes to neurodegeneration (Nave, 2010). Therefore, it would be interesting to 
distinguish the intrinsic properties of NG2+ glia from environmental influences in regard to 
their proliferation/ differentiation behavior. Such studies would certainly help to shed more 
light on the development of demyelinating diseases, e.g. Multiple Sclerosis.  
 
4 Discussion 74 
4.2 Heterogeneity of NG2+ glia 
Although NG2+ cells show mainly a homogenous antigen expression pattern (Figure 2), 
studies analyzing properties of NG2+ glia in different brain regions, e.g. cell cycle length, 
progeny and electrophysiological characteristics, suggest a region-dependent heterogeneity 
amongst the NG2+ cell population. Several publications could show that NG2+ cells in the 
cortical WM have an accelerated cell cycle speed compared to NG2+ progenitors in the 
cortical GM (Psachoulia et al., 2009; Rivers et al., 2008). This decrease in cell cycle length in 
the WM could be correlated to an increased differentiation of NG2+ progenitors to mature 
oligodendrocytes (Dimou et al., 2008; Kang et al., 2010; Psachoulia et al., 2009; Rivers et al., 
2008). Indeed, fate-mapping analysis of the Olig2::CreERTM mouse line extended this regional 
heterogeneity by showing that NG2+ cells in the WM generate more myelinating 
oligodendrocytes while NG2+ progeny in the cortical GM remain largely NG2+ and give rise 
to few mature oligodendrocytes (Dimou et al., 2008). Kang et al. (2010) confirmed a cortical 
GM and WM difference, although they could demonstrate that NG2+ cells in both cortical 
areas are able to generate myelinating oligodendrocytes (Kang et al., 2010). These 
contradicting results might be due to differences in the mouse lines, used in both studies. 
First, the recombination rate is higher in the PDGFRα-CreERTM mice than in Olig2::CreERTM 
mice (Dimou et al., 2008; Kang et al., 2010). Second, the Olig2::CreERTM mouse line might 
restrict the analysis to a distinct subpopulation of NG2+ cells as mainly cells with high Olig2 
levels were recombined (as discussed in Simon et al., 2011a). Instead, Kang et al. (2010) 
labeled a broader NG2+ cell population independent of their Olig2 expression level. 
However, there seems to be a consistency about the diversity of NG2+ cells between cortical 
GM and WM that is not only reflected in their speed of proliferation and differentiation, but 
probably also in their receptor expression and structural relationship to neurons and 
astrocytes (reviewed by Maldonado et al., 2011). How is this diversity of cortical NG2+ glia 
achieved? One assumption could be an intrinsic heterogeneity of cortical NG2+ cells. 
Therefore, NG2+ cells might be pre-primed based on their diverse developmental origin by 
being progeny of the lateral and dorsal wall of the subventricular zone and the diencephalon 
(Kessaris et al., 2006; Psachoulia et al., 2009). So far studies failed to show any correlation of 
the fate to distinct developmental origins (Psachoulia et al., 2009). Therefore, regional 
diversity of NG2+ glia might be intrinsically instructed, independent of the developmental 
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origin, or rather being instructed by environmental cues, e.g. neuronal activity (as discussed 
below).  
Nevertheless, all published studies can show likewise a continuous differentiation of NG2+ 
glia to mature and even to myelinating oligodendrocytes in the adult CNS (Barnabe-Heider et 
al., 2010; Dimou et al., 2008; Kang et al., 2010; Psachoulia et al., 2009; Rivers et al., 2008; 
Simon et al., 2011a). These data suggest de novo myelination, supported by results showing 
an increased number of myelinated axons during adulthood (Nunez et al., 2000; Yates and 
Juraska, 2007). Also a life-long turnover of myelin with continuous de- and re-myelination 
could be possible as there is no obvious change in brain weight (before the onset of age-
related decline) and only localized volume plasticity is detectable under physiological 
conditions (reviewed by Sowell et al., 2004). However, the differentiation rate of mature 
oligodendrocytes towards myelinating oligodendrocytes in the adult cortical GM and WM is 
low compared to the number of mature oligodendrocytes being present and newly 
generated from NG2+ cells in the adult CNS (Dimou et al., 2008; Simon et al., 2011a). This 
raises questions about the biological relevance of the continuous generation of these mature 
oligodendrocytes in vivo. One possible function of mature oligodendrocytes is to alter the 
conduction velocity of neurons locally as a possible adaptation mechanism to neuronal firing 
(Nave, 2010; Sanchez et al., 1996). In addition, oligodendrocytes might be relevant to 
support axonal integrity and survival (Nave, 2010). For example, loss of peroxisomes in 
oligodendrocytes can cause neurodegeneration (Kassmann et al., 2007), whereas lack of 
peroxisomes in astrocytes and even in neurons has no impact on neuronal integrity 
(Bottelbergs et al., 2010). Additionally, the direct cell-to-cell communication between 
mature oligodendrocytes and neurons might be important to maintain the axonal integrity 
as alterations in their signalling can cause progressive axonal loss as shown for non-
myelinating Schwann cells – the cell type in the peripheral nervous system equivalent to 
oligodendrocytes (Chen et al., 2003). Taken together, the precise biological impact of the 
diverse NG2+ progenitors and their progeny on neuronal survival and brain homeostasis in 
the adult CNS has just started to be elucidated and requires further analysis in regard to 
NG2+ glia heterogeneity.  
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4.3 Regulation of proliferation and differentiation of NG2+ glia by neuronal 
activity 
Early in vitro data of primary oligodendrocyte cultures suggested a cell-intrinsic timer 
mechanism in NG2+ glia that measures the rounds of cell division (Raff, 2006) or time in 
general (Gao et al., 1997) before these cells start to differentiate. However, co-cultures of 
NG2+ cells together with neurons pointed to additional regulatory mechanisms for their 
proliferation/differentiation, comprising environmental cues that might outweigh the 
intrinsic timer (Rosenberg et al., 2008). In line with this, there are observations showing that 
NG2+ cells can keep their synaptic connections, e.g. to neurons, during cell division (Ge et 
al., 2009; Tanaka et al., 2009), whereas they receive less neuronal input upon differentiation 
(De Biase et al., 2010; Kukley et al., 2010). Not only the contact of NG2+ cells to neurons but 
also neuronal activity can influence the rate of proliferation/differentiation of NG2+ glia in 
the intact adult cortex. Upon increased physical activity the number of NG2+ progenitors is 
temporarily decreased while their differentiation is enhanced (Simon et al., 2011a). The 
remaining proliferating cells are not randomly localized within the cortical GM compared to 
control mice. Instead, these NG2+ progenitors show a specific column-like distribution 
within the somatosensory and motor cortex upon increased physical activity (Simon et al., 
2011a). This proliferative pattern might be associated with neuronal activity as a 
synchronized firing of neurons in a column-like structure upon stimulation has been already 
described (Opris et al., 2011; Zhang and Alloway, 2004). In addition, NG2+ progenitors 
prematurely leave the G1-phase and differentiate into oligodendrocytes, thereby supporting 
previous publications (Barres and Raff, 1993; Demerens et al., 1996; Li et al., 2010). Although 
direct stimulation of neurons resulted in an increase in proliferating cells in the spinal cord 
WM (Li et al., 2010), NG2+ cells in the cortical GM decrease in proliferation temporarily upon 
a two weeks period of voluntary physical exercise (Simon et al., 2011a). This difference could 
be due to different experimental approaches or the regional diversity of NG2+ glia (see 
discussion above about heterogeneity of NG2+ cells). However, NG2+ glia can compensate 
the decrease in proliferation during an additional two weeks period on the running wheel (in 
total: four weeks of increased physical activity; Simon et al. unpublished data). In addition, 
the generation and maintenance of new mature oligodendrocytes in the cortical GM during 
voluntary exercise seems to be dependent on increased neuronal activity: While the number 
of mature oligodendrocytes decreases during a subsequent period without running wheels, 
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BrdU+ oligodendrocytes are maintained during a prolonged period of voluntary exercise 
(Simon et al., unpublished data). Therefore, this neuronal activity-dependent differentiation 
mechanism of NG2+ cells might support distinct neuronal networks and may contribute to 
improved behavior. For example practicing playing the piano is related to structural changes 
in the human cortical GM and WM (Bengtsson et al., 2005; Fields, 2005; Gaser and Schlaug, 
2003). Along this line, Juraska et al. (1988) could show that an enriched environment results 
in an increased number of myelinated axons in the WM of adult rodents (Juraska, 1998). In 
contrast, reduced neuronal activity, e.g. by postnatal visual deprivation, resulted in a delay 
of myelination of the optic nerve and a delayed maturation of retinal neurons (Gyllensten 
and Malmfors, 1963). Overall this neuronal activity-dependent mechanism of 
proliferation/differentiation of NG2+ cells could be an additional form of plasticity in the 
adult brain whereby distinct neuronal circuits might be improved, newly generated or 
stabilized. However, it remains open whether neuronal stimulation not only results in the 
generation of mature oligodendrocytes, but also in myelinating oligodendrocytes and if this 
is directly correlated with a permanent improved behavior of adult mammals. In addition, it 
would be interesting to analyze the molecular correlation to this neuronal activity-
dependent plasticity. In vitro data suggest that proliferation of NG2+ cells which, in turn, 
could be regulated for example (1) by a neuronal release of glutamate, adjacent activation of 
AMPA receptors on NG2+ cells that in turn could result in the activation of cAMP response 
binding element (CREB; (Redondo et al., 2007)) or (2) by the secretion of PDGF (a known 
mitogenic signal for NG2+ glia) from astrocytes due to neuronal activity (Figure 8; (Barres 
and Raff, 1993; Calver et al., 1998; Engel and Wolswijk, 1996)).  
Little is known about mitogenic signals or even cell cycle inhibitors that are released by 
neurons and astrocytes upon neuronal activity in vivo. Instead, more data exist regarding the 
differentiation of NG2+ cells upon electrical stimulation of neurons. Pathways, that could be 
stimulated upon neuronal activity, are the expression of serum-response factor (SRF) in 
neurons (Knoll and Nordheim, 2009; Stritt et al., 2009), resulting in the transcriptional 
inhibition of connective tissue growth factor (CTGF) – a neuronal paracrine factor, known to 
sequester extracellular insulin-like growth factor 1 (IGF 1; (Chong and Chan, 2010)). 
Therefore, IGF 1 could bind to its receptor on NG2+ cells that would result in differentiation, 
at least in vitro (Cui et al., 2010; Galvin et al., 2010). Besides neuronal SRF, the release of ATP 
by neurons could influence the proliferation and differentiation of NG2+ glia. Neuronal ATP 
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release can result for example in the secretaion of physiological concentrations of leukemia 
inhibitory factor (LIF) by astrocytes that in turn could promote maturation of NG2+ cells 
(Ishibashi et al., 2006). In addition, adenosine (a metabolite of ATP) can inhibit the 
proliferation of NG2+ cells and promote their differentiation dependent on neuronal activity 
(Stevens et al., 2002). Besides the above mentioned molecules, there is a wide range of 
other factors, being expressed by neurons (e.g. Jagged 1, Lingo and PSA-NCAM) or secreted 
by other cell types that can influence the differentiation of NG2+ glia (Figure 8; (Chong and 
Chan, 2010; Emery, 2010; Kremer et al., 2011)). However, the majority of these data derived 
from in vitro experiments and the analysis of neonatal NG2+ cells 
 
Figure 8 Scheme summarizing the neuronal influence on the differentiation of NG2+ cells. Possible neuronal cues are 
shown that can either enhance or block the differentiation of NG2+ glia towards myelinating oligodendrocytes. (adapted 
from Emery 2010) 
The major intracellular pathways in NG2+ cells involved in the regulation 
proliferation/differentiation are the Notch and Wnt/BMP pathways that act as negative 
regulators, blocking the differentiation of NG2+ cells (Figure 8; (Emery, 2010; Feigenson et 
al., 2011; Li and Richardson, 2009; Teo and Kahn, 2010; Wang et al., 1998; Zhou and 
Armstrong, 2007)). Otherwise, sonic hedgehog (Shh; (Ulloa and Marti, 2010)), released by 
neurons in an activity-dependent way (Beug et al., 2011), promotes the differentiation of 
NG2+ glia at least during development (Nery et al., 2001). Although the differentiation of 
NG2+ cells seems to be tightly regulated by neuronal activity, it remains still open if neuronal 
stimulation has a direct impact on the proliferation rate of adult NG2+ glia. It could also be 
possible that the proliferation of NG2+ cells is a secondary consequence of the 
differentiation of NG2+ cells upon neuronal activity: Once a NG2+ cell differentiates, 
surrounding NG2+ cells could start to proliferate in order to maintain the NG2+ cell density 
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within the CNS as shown after four weeks of voluntary exercise (Simon et al., unpublished 
data). This would suggest that neuronal activity might largely influence NG2+ cell 
differentiation. Furthermore, it is still not clear whether the communication between 
neurons and NG2+ glia is uni- or bidirectional. Therefore, ablating NG2+ cells in the adult 
CNS might reveal new insights in the plasticity of neuronal networks and its behavioral 
impact. In addition, studying the reaction of NG2+ glia under pathological conditions, e.g. 
neuronal hyperexcitibility (epilepsy) or transmitter imbalance (autism), might shed new light 
on the disease mechanisms.  
 
4.4 Reaction of NG2+ glia to acute injury 
The response of NG2+ glia to trauma occurs with a similar temporal profile as microglia. 
Moreover, NG2+ glia react not only by cellular hypertrophy and up-regulation of NG2, but 
also by increased proliferation around the injury side (Simon et al., 2011a). These data are 
consistent with other publications analyzing either acute lesion (stab wound as well as cryo 
injuries) in the cortical GM (Buffo et al., 2005; Hampton et al., 2004; Rhodes et al., 2006; 
Tatsumi et al., 2005) and in the cerebellum (Levine, 1994) or demyelinating lesion in the 
spinal cord (Watanabe et al., 2002). The morphological and proliferative reaction of NG2+ 
cells is transient and decreases to basal levels already 14 days post injury (Simon et al., 
2011a). This decline in NG2+ glial reactivity again correlates again to the decrease in 
reactivity of microglia. Rhodes et al. (2006) showed that the response of NG2+ cells to 
traumata is dependent on the break-down of the BBB. Signals, being secreted by 
macrophages and platelets (e.g. tumor necrosis factor α, transforming growth factor β, 
interleukin 1α and interferon γ), can cause morphologically alterations of NG2+ cells towards 
a reactive phenotype. In addition, NG2+ cells achieve the fast proliferative response to acute 
traumata by re-entering the cell cycle and by shortening its length (Simon et al., 2011a), 
consistent with data from spinal cord lesions (Watanabe et al., 2002). This short cell cycle 
length after injury is comparable to postnatal stages (as determined by Psachoulia et al. 
(2009)), thereby supporting the hypothesis that NG2+ glia can recapitulate developmental 
stages upon pathological conditions (Chong and Chan, 2010). Indeed, in vitro data support 
the concept that adult NG2+ cells can accelerate their cell cycle speed in the presence of 
distinct mitogens, e.g. PDGF, neuregulin-1 and increased cAMP levels (Shi et al., 1998), or 
decrease their proliferation by inhibitory signals, e.g. ADP/ ATP (Agresti et al., 2005b) and 
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interferon-γ (Agresti et al., 1996). In addition, numerous factors have been shown or 
proposed to regulate the proliferation of NG2+ cells after lesion in vivo, as for example 
factors that are released by injured axons and endothelial cells or by neighboring 
oligodendrocytes and astrocytes (reviewed in (Fawcett and Asher, 1999; Levine et al., 2001). 
These molecules include growth factors that are up-regulated after injury, e.g. PDGF, FGF, 
IGF and CNTF (Barres and Raff, 1994; Fortin et al., 2005; Liu et al., 1994; Mason et al., 2003; 
Redwine and Armstrong, 1998; Tripathi and McTigue, 2008). In particular, inflammatory 
lesions induce local production of several cytokines and chemokines (McTigue and Tripathi, 
2008) which, together with other blood derived factors, might influence the proliferation of 
NG2+ cells (Kerstetter et al., 2009; Rhodes et al., 2006; Taylor et al., 2010). In addition, other 
pathways might have an impact on the reactivity of NG2+ glia upon injury, e.g. Shh, Wnt, 
Notch and BMP signalling (Amankulor et al., 2009; Boda and Buffo, 2010). However, the 
effects of mitogens on NG2+ glia might vary in different brain areas and injury paradigms 
and could also be dependent on the developmental stage (Mason and Goldman, 2002; 
Pfeiffer et al., 1993).  
The recapitulation of developmental stages of NG2+ cells upon acute injury might not only 
be limited to the cell cycle speed, but could also compromise a fate change towards 
astrocytes. Indeed, several studies showed that a small subpopulation of adult NG2+ glia can 
up-regulate intermediate filaments, e.g. GFAP, vimentin and nestin, upon acute injury 
(Alonso, 2005; Busch et al., 2010; Komitova et al., 2011; Sellers et al., 2009; Tatsumi et al., 
2008). So far, these molecules are known to be expressed in reactive astrocytes after trauma 
in the adult brain parenchyma (Robel et al., 2011b) and in adult stem cells (Kriegstein and 
Alvarez-Buylla, 2009). In addition, our fate-mapping data of the Sox10-iCreERT2 mouse line 
support the expression of astrocytic antigens (e.g. GFAP, S100β and vimentin) after acute 
injury in progeny of the oligodendrocyte lineage (Simon et al., unpublished data). This 
observation is supported by recent fate-mapping study, using NG2-CreERTM mice (Komitova 
et al., 2011) suggesting that some NG2+ cells could adopt at least partially astrocytic-like 
features. However, the generation of astrocytes from NG2+ cells is controversially discussed 
as others failed to confirm it, e.g. in fate-mapping analysis of Olig2+ progenitors in lesions in 
Olig2::CreERTM mice (Barnabe-Heider et al., 2010; Dimou et al., 2008). The discrepancy 
between these studies could be due to differences between the mouse lines, e.g. particularly 
the different recombination rate (as already discussed herein) and the altered 
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recombination of distinct cell types. The Olig2::CreERTM mouse line is characterized by 
recombining low numbers of parenchymal astrocytes already in the intact CNS (Dimou et al., 
2008) while recombined cells in Sox10-iCreERT2 mouse line are restricted to the 
oligodendrocyte lineage (Simon et al., 2011b). In addition, the fate-mapping analysis of the 
Sox10-iCreERT2 mice after injury revealed that astrocytic-like NG2+ cells probably derive 
from non-dividing NG2+ cells as they do not incorporate BrdU after stab wound injury 
(Simon et al., unpublished data). Therefore, these cells also remained undetectable in other 
studies, focusing only on proliferating NG2+ glia (Simon et al., 2011a). Additional data even 
suggest that these astrocytic-like subpopulation of NG2+ cells appear only transient 
(Komitova et al., 2011; Sellers et al., 2009) or these cells upregulate only transiently GFAP, 
S100β and vimentin. Furthermore, this subpopulation of NG2+ cells seems to be related to 
acute traumata while chronic/ degenerative lesion paradigms lack them (Kang et al., 2010).  
Nevertheless, less is known about the function of NG2+ cells around the injury site. Ablation 
of proliferating glial cells after acute trauma suggested an improved axonal recovery (Rhodes 
et al., 2003). Whether this is due to a decrease in microglia, astrocytes or NG2+ glia, as all of 
them proliferate after acute injury, is still unkown. In addition, the astrocytic-like NG2+ cells 
are only detectable during the acute phase of lesions (Komitova et al., 2011; Sellers et al., 
2009) and might be associated with phagocytic functions (Sellers et al., 2009), e.g. by 
removing myelin debris that is another toxic component in the lesion site (Nave, 2010). To 
gain further insights in the contribution of NG2+ cells within the glial scar it would be 
important to define new molecules, allowing to distinguish “quiescent” NG2+ cells from 
reactive ones and to ablate NG2+ glia from the lesion.  
 
4.5 Sox10-iCreERT2 mouse line – a new tool to fate-map neural crest cells 
and the oligodendrocyte lineage 
In this study, I generated a mouse line to overcome the low recombination rate in NG2+ 
cells, as published for other mouse lines (Dimou et al., 2008; Zhu et al., 2011), and yet being 
specific to the neural crest and to the oligodendrocyte lineage in the adult CNS (Simon et al., 
2011b). This Sox10-iCreERT2 mouse line is indeed unique as the fate of Sox10+ cells can be 
analyzed at distinct stages. In contrast, previously published mouse lines, e.g. Sox10-Cre or 
Sox 10-Venus, label either Sox10+ cells already at embryonic stages or only transiently when 
the Sox10 promoter is active, respectively (Shibata et al., 2010; Stine et al., 2009). In 
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addition, the expression from both endogenous Sox10 alleles is spared in the BAC-transgenic 
Sox10-iCreERT2 mouse line and thereby circumventing a heterozygote phenotype, that is 
characterized e.g. by partial aganglionosis in the intestine of the Sox10::lacZ and Sox10::rtTA 
mice (Britsch et al., 2001; Ludwig et al., 2004; Paratore et al., 2001). Taken together the 
results obtained so far, this new Sox10-iCreERT2 mouse line can reveal new insights in the 
neural crest lineage due to its unique features. We have now direct evidence that pericytes 
in the adult CNS are the progeny of neural crest. This data support similar observations in 
the thymus (Muller et al., 2008) and are in line with results obtained from quail-chick 
transplantation experiments (Korn et al., 2002) and in the human tissue plasminogen 
activator-Cre mice (Pietri et al., 2003). Recently, neural crest derivatives gained in 
importance as these cells display stem cell capacity and can be reprogrammed to other cell 
types (Binder et al., 2011; Dupin et al., 2007; Zhao and Prather, 2011). In particular, adult 
cortical pericytes have been shown to be reprogrammed to neurons in vitro (Sanchez et al., 
2011, under revision) and might serve as a new endogenous source for brain repair upon 
lesion. In general, the Sox10-iCreERT2 mice recapitulate the endogenous Sox10 expression in 
the PNS and CNS during development and in the adult. For example, recombination in the 
adult CNS of Sox10-iCreERT2 mice will label exclusively the oligodendrocyte lineage with high 
efficiency in contrast to previous published mouse lines using the Olig2, NG2 and PDGFRα 
promoter (Dimou et al., 2008; Kang et al., 2010; Rivers et al., 2008; Zhu et al., 2011). This 
highly efficient recombination of Sox10+ cells is not only limited to the CNS but also 
detectable in the PNS. Therefore, the Sox10-iCreERT2 mouse line is a useful tool to 
conditionally ablate genes in Sox10+ cells to obtain more information about the Sox10+ 
lineage. This is of particular importance as Sox10+ cells can be involved in a variety of 
diseases in peripheral organs as well as in the CNS, e.g. melanoma, Wardenburg-
Hirschsprung disease, glioma, acute traumata, MS, schizophrenia and autism (Agnarsdottir 
et al., 2010; Britsch et al., 2001; Carmody and Lewis, 2010; Iwamoto et al., 2005; Lim et al., 
2011; Nishiyama et al., 2009; Simon et al., 2011a).  
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4.6 A translational perspective: NG2+ glial biology towards clinical 
application 
NG2+ glia compose not only the major dividing cell population in the brain parenchyma of 
rodents, but also in humans (Geha et al., 2010; Nunes et al., 2003). Therefore, these cells are 
susceptible for oncogenic mutations that might result in tumor formation (Visvader, 2011). 
Indeed, NG2+ cells are the predominant proliferative population in different types of glioma 
(Chekenya and Pilkington, 2002; Liu et al., 2011; Shoshan et al., 1999) and are shown to be 
the origin of these tumors (Lindberg et al., 2009; Liu et al., 2011). Glioma are the most 
common brain tumors with a high rate of malignancy that goes along with poor survival 
probability (Norden and Wen, 2006). Common treatments besides operations are the 
administration of cytostatic drugs and the radiation of tumorigenic brain areas that are both 
strategies targeting proliferating cells. Liu et al. (2011) labeled a profound number of dividing 
tumorigenic NG2+ cells within one week BrdU pulse, suggesting that these cells might have 
an accelerated cell cycle speed compared to non-tumorigenic NG2+ progenitors (Simon et 
al., 2011a). However, the cell cycle of tumorigenic NG2+ glia might be too slow to be 
efficiently targeted by cytostatica with short half-life times, e.g. Temozolomide 
(EssexPharma, 2009). In addition, brain-permeable cytostatica might also hit non-
tumorigenic NG2+ cells that could result in an increased proliferation of surrounding NG2+ 
glia (as discussed above). In addition, radiation might, for example, cause neurotoxicity, 
disruption of BBB, inflammation and demyelination (Panagiotakos et al., 2007; Perry and 
Schmidt, 2006; Zhao and Robbins, 2009) that are events associated with a high reactivity of 
NG2+ glia (as discussed above). Overall, cytostatic drugs and radiation might increase the 
likelihood of a tumorigenic transformation of NG2+ cells and could probably be one 
explanation for the high chemoresistance and recurrence rate of glioma (Giannopoulos and 
Kyritsis, 2010). Therefore, there is the need to distinguish non-tumorigenic NG2+ progenitors 
from their tumorigenic counterparts on a molecular basis to develop novel cellular-specific 
pharmacological approaches in glioma therapy.  
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A1 List of abbreviations 
 
µm Micrometer 
AChR Acetylcholine receptor 
AMPA α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
APC (CC1) Adenomatosis polyposis coli 
AraC Cytosine-D-arabinofuranoside 
ASPA Aspartoacylase 
ATP Adenosine triphosphate 
BAC Bacterial artificial chromosome 
BBB Blood brain barrier 
BDNF Brain-derived neurotrophic factor 
BLBP Brain lipid binding protein 
BMP Bone morphogenic protein 
bp Base pairs 
BrdU 5’-bromo-desoxyuridine 
Ca2+ Calcium ion 
cAMP Cyclic adenosine monophosphate 
CC1 See APC 
CD11b Cluster of differentiation 11b 
CD45 Cluster of differentiation 45 
CNS Central nervous system 
CNTF Ciliary neurotrophic factor 
CsCl Cesium chloride 
CTGF Connective tissue growth factor 
d Day 
DAPI 4’,6’-diamidino-2-phenylindole 
Dcx Doublecortin 
DIG Digoxigenin 
dpi Days post injury 
dpr Days post recombination 
DRG Dorsal root ganglia 
E Embryonic day 
e.g. Exempli gratia 
ECM Extracellular matrix 
EGFR Epidermal growth factor receptor 
EPSC Excitatory postsynaptic current 
ER Estrogen receptor 
FGF Fibroblast growth factor 
G gram 
GABA γ-aminobutyric acid 
GDNF Glial cell line derived neurotrophic factor 
GFAP Glial fibrillary acidic protein 
GFP Green fluorescent protein 
GLAST Alias Slc1a3 – solute carrier family 1 (glial high affinity glutamate transporter), member 3 
Glu Glutamate 
GM Gray matter 
Gp Guinea pig 
GPR17 G-protein coupled receptor 17 
GSTπ Glutathione-S-transferase π 
h Hour 
HDAC Histon deacetylase  
Hes Hairy and enhancer of split 
Iba1 Induction of brown adipocytes 1 
iCreERT2 Improved Cre recombinase fused to a truncated estrogen receptor 
Id Inhibitor of differentiation 
IGF Insulin-like growth factor 
IL interleukin 
IPSC Inhibitory postsynaptic current 
JAMA Junctional adhesion molecule A 
kb Kilo base pairs 
kg Kilogram 
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lacZ β-galactosidase 
LGE Lateral ganglionic eminence 
LI Labeling index 
LIF Leukemia inhibitory factor 
Lingo Leucine rich repeat and Ig domain containing 
m Mouse 
M Molar 
MAG Myelin-associated glycoprotein 
Mash Ascl1 – achaete-scute complex homolog 1 
MBP Myelin basic protein 
mg Milligram 
MGE Medial ganglionic eminence 
min Minute 
mm Millimeter 
MMP Metalloproteinase 
MOG Myelin oligodendrocyte glycoprotein 
MS Multiple sklerosis 
Neo Neomycine 
NeuN Neuronal nuclear antigen 
NG2 Neuron-glia antigen 2 
NGF Nerve growth factor 
NT Neurotrophin 
OHT 4-hydroxy tamoxifen 
OLIG2 Oligodendrocyte transcription factor 2 
OPC Oligodendrocyte precursor cell 
PAC P1-derived artificial chromosome 
PDGF Platelet-derived growth factor 
PDGFRα Platelet-derived growth factor α receptor 
PFA Paraformaldehyde 
PhD Doctor of Philosophy 
PLP/ DM20 Myelin proteolipid protein 
PNS Peripheral nervous system 
PSA-NCAM Poly sialated-neural cell adhesion molecule 
R26R Rosa26 reporter mouse line, expressing β-galactosidase 
Rb Rabbit 
Rt Rat 
rtTA Tetracycline reverse transcription activator 
s.c. Subcutan 
S100β S100 calcium binding protein β 
SEM Standard error of the mean 
Shh Sonic hedgehog 
Sox SRY (sex determining region Y)-related high mobility group box protein 
SRF Serum response factor 
TAM Tamoxifen 
Tcf Transcription factor 
TGF T growth factor 
TH1 T-helper cell 1 
TH2 T-helper cell 2 
TIMP Tissue inhibitory of metalloproteinase 
TM Tamoxifen 
TNC Tenascin 
TNF Tumor necrosis factor 
UTR Untranslated region 
WM White matter 
Wnt Wingless-related MMTV integration site 
Wt Wildtype 
YY Ying and Yang 
z.B. Zum Beispiel 
Z/EG GFP reporter mouse line 
ZNS Zentrales Nervensystem 
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